| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.081 | 0.09 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.09 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |